Trials / Terminated
TerminatedNCT02357849
Fluoxetine vs Aripiprazole Comparative Trial (FACT)
The Role of Antidepressants or Antipsychotics in Preventing Psychosis: Fluoxetine vs Aripiprazole Comparative Trial (FACT)
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 9 (actual)
- Sponsor
- Northwell Health · Academic / Other
- Sex
- All
- Age
- 12 Years – 25 Years
- Healthy volunteers
- Not accepted
Summary
We are conducting a randomized, 24-week, double-blind study, comparing fluoxetine with aripiprazole in 48 patients with attenuated positive symptoms at a level of at least moderate severity.
Detailed description
To Compare Fluoxetine and Aripiprazole on All-cause Discontinuation/Need to Add Another Psychiatric Medication, Symptomatic Improvement, and Adverse Effects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Aripiprazole | see arm description |
| DRUG | Fluoxetine | see arm description |
Timeline
- Start date
- 2014-07-01
- Primary completion
- 2022-04-04
- Completion
- 2022-04-04
- First posted
- 2015-02-06
- Last updated
- 2023-11-15
- Results posted
- 2023-11-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02357849. Inclusion in this directory is not an endorsement.